title: Intermittent vemurafenib therapy in malignant melanoma.
authors.affiliation: Department of Dermatology and Allergology, University of Ulm, Ulm, Germany.
authors.forename: Nicolai
authors.initials: N
authors.lastname: Treiber
authors.affiliation: Department of Dermatology and Allergology, University of Ulm, Ulm, Germany.
authors.forename: Margit Anna
authors.initials: MA
authors.lastname: Huber
authors.affiliation: Department of Dermatology and Allergology, University of Ulm, Ulm, Germany.
authors.forename: Lars Alexander
authors.initials: LA
authors.lastname: Schneider
authors.affiliation: Department of Dermatology and Allergology, University of Ulm, Ulm, Germany.
authors.forename: Karin
authors.initials: K
authors.lastname: Scharffetter-Kochanek
authors.affiliation: Department of Dermatology, University Hospital of the Paracelsus Medical Private University, Nuremberg, Germany.
authors.forename: Erwin
authors.initials: E
authors.lastname: Schultz
authors.affiliation: Department of Dermatology, University Hospital of the Paracelsus Medical Private University, Nuremberg, Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Debus
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D006801:Humans; D008545:Melanoma / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D000077484:Vemurafenib / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D000077484:Vemurafenib